chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 12.0
Sex: M
Vaccine: HEPA, MNQ, TDAP, VARCEL
Symptoms: Rash erythematous, Skin warm
Clinical narrative: Days after getting Hep A and Tdap in left arm.  Red rash 9 x 9 cm with mild warmth.  Resulted in a followup visit to doctor on 7-6-10.  Antibiotics were rx if worsening symptoms to start and finish (Bactrim).
Age: 2.0
Sex: M
Vaccine: IPV
Symptoms: Wrong drug administered
Clinical narrative: Incorrect vaccine administered.  Child was given IPV instead of Prevnar 13 booster.  IPV was drawn up for 15 month old sister, and then administered to 3 year old child.
Age: 64.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Injection site erythema, Myalgia, Pyrexia
Clinical narrative: Severe redness around injection site, fever to 103 with myalgias.  Redness ended up involving the entire left upper arm.
Age: 0.51
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Hypophagia, Irritability
Clinical narrative: Increased fussiness.  Decreased PO. intake.
Age: 1.24
Sex: M
Vaccine: DTAPIPVHIB, MMR
Symptoms: Blood amylase, Full blood count, Mumps antibody test, Parotid gland enlargement
Clinical narrative: Massive swelling of parotid gland.
Age: 11.0
Sex: F
Vaccine: HEPA, MNQ, TDAP
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: Localized swelling, redness, warmth.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Rash papular
Clinical narrative: Raised rash on legs, arms, stomach, and cheeks. No fever, no itching, no pain. Vaccines given on 6/29/10. Rash started on 7/4/10.
Age: 44.0
Sex: F
Vaccine: HEPA, MMR, TDAP, VARCEL
Symptoms: Discomfort, Erythema, Induration, Injection site erythema, Injection site pruritus
Clinical narrative: Pt states site of Varicella inj started itching 6/30 and it started swelling at site. Nurse noted redness and swelling and heat at site on 7/1/10 and pt cont. to c/o itching. By 7/20 pt states was much worse, a hard knot developed and redness was progressing all around arm and very uncomfortable.
Age: 44.0
Sex: F
Vaccine: HEPA, MMR, TDAP, VARCEL
Symptoms: Injection site swelling, Injection site warmth, Nodule, Pruritus
Clinical narrative: Pt states site of Varicella inj started itching 6/30 and it started swelling at site. Nurse noted redness and swelling and heat at site on 7/1/10 and pt cont. to c/o itching. By 7/20 pt states was much worse, a hard knot developed and redness was progressing all around arm and very uncomfortable.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Cellulitis, Injection site erythema, Injection site pain, Injection site rash, Injection site swelling
Clinical narrative: Redness, pain, swelling, rash-like appearance at site of injection.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Oropharyngeal pain, Swollen tongue
Clinical narrative: Pt's mother called in the next day to report that her child had a swollen tongue and c/o sore throat - Instructed to give BENADRYL for reaction, but mom said the symptoms had already resolved.
Age: 77.0
Sex: M
Vaccine: PPV, TD
Symptoms: Injection site erythema, Injection site pain, Injection site warmth, Pain in extremity
Clinical narrative: Pt began c/o rt arm pain in the evening of 7/1/10. No redness or swelling was noted to arm at that time. On 7/2/10 at aprox 1930 patient c/o rt arm pain and was found to have redness, swelling, heat and extreme pain from deltoid to just distal of elbow. Patient seen by ANP. Symptoms remain-less pain today 7/6/10. Pt being treated with MOTRIN, TYLENOL, KENALOG; prednisone, vancomycin, and ROCEPHIN.
Age: 34.0
Sex: M
Vaccine: HEP
Symptoms: Full blood count normal, Laboratory test normal, Nausea, Pyrexia, Vomiting
Clinical narrative: Nausea, vomiting, fever x 5 d began 2 hrs after vaccine.
Age: 64.0
Sex: M
Vaccine: FLUX
Symptoms: Alanine aminotransferase normal, Aspartate aminotransferase normal, Blood albumin decreased, Blood bilirubin normal, Computerised tomogram abnormal
Clinical narrative: This case was reported in a literature article and described the occurrence of hemorrhagic cerebral infarction in a 64-year-old male subject who was vaccinated with INFLUENZA virus vaccine (manufacturer unspecified). Concurrent medical conditions included atrial fibrillation, chronic obstructive pulmonary disease, depression, diabetes mellitus (type 2), gastroesophageal reflux, hypercholesterolemia and hypertension. Concurrent medications included warfarin 5 mg every other day alternating with 2.5 mg, celecoxib 200 mg as needed for pain, ipratropium/albuterol inhaler 2 puffs twice daily, diltiazem 120 mg twice daily, metformin 500 mg twice daily, hydrochlorothiazide/losartan 25 mg/100 mg daily, escitalopram 20 mg daily, lansoprazole 30 mg daily, propranolol 40 mg twice daily, and ezetimibe/simvastatin 10 mg/40 mg daily. All medication regimens were unchanged for at least 6 months. None of his medications was altered. The patient had been seen in the clinic 5 weeks prior to presentation. At that time, his INR was 2.0 and he received unspecified dose of INFLUENZA vaccine (unknown route, unknown injection site). Lot number was not available. 5 weeks after vaccination with INFLUENZA vaccine, the subject was hospitalized after becoming unresponsive at home. At the admission, the patient had been unresponsive for approximately 1 hour. The patient was experiencing rectal bleeding for the previous 2 days. The initial international normalized ratio (INR) was greater than 15; INR values over the previous 6 months were relatively stable. Relevant test were performed and showed the following results: Hemoglobin: 8.3 g/dL (normal range 14-18); Hematocrit: 24% (normal range 42-52); Platelet count: 412 x 10^3/uL (normal range 150-430); low serum albumin: 3.1 g/dL (normal range 3.5-5.0); total bilirubin: 0.8 mg/dL (normal range 0.2-1.0); aspartate aminotransferase: 16 IU/L (normal range 10-42); alanine aminotransferase: 12 IU/L (normal range 10-40); blood pressure: 166/60 mm Hg, heart rate: 62 beats/min; respiration rate: 16 breaths/min; temperature was not documented. A non-contrast computed tomography scan of the head revealed a large parenchymal hemorrhagic infarction involving the left temporal, parietal, and occipital lobes. The radiologist noted a significant mass effect including 12mm rightward midline shift and impending uncal herniation. The subject was treated in the emergency department with Nitroglycerin infusion to maintain systolic blood pressure in the range of 140-160 mm Hg as well as the infusion of 4 units of fresh frozen plasma and 10 mg of vitamin K. Following a neurosurgery evaluation, it was determined that nothing meaningful could be done to alter the patient's outcome positively. Comfort measures were implemented and the patient died approximately 17 hours after admission. The author considered the events were possibly related to the interaction between warfarin and vaccination with INFLUENZA vaccine.
Age: 64.0
Sex: M
Vaccine: FLUX
Symptoms: Computerised tomogram head, Death, Haematocrit decreased, Haemoglobin decreased, Haemorrhagic cerebral infarction
Clinical narrative: This case was reported in a literature article and described the occurrence of hemorrhagic cerebral infarction in a 64-year-old male subject who was vaccinated with INFLUENZA virus vaccine (manufacturer unspecified). Concurrent medical conditions included atrial fibrillation, chronic obstructive pulmonary disease, depression, diabetes mellitus (type 2), gastroesophageal reflux, hypercholesterolemia and hypertension. Concurrent medications included warfarin 5 mg every other day alternating with 2.5 mg, celecoxib 200 mg as needed for pain, ipratropium/albuterol inhaler 2 puffs twice daily, diltiazem 120 mg twice daily, metformin 500 mg twice daily, hydrochlorothiazide/losartan 25 mg/100 mg daily, escitalopram 20 mg daily, lansoprazole 30 mg daily, propranolol 40 mg twice daily, and ezetimibe/simvastatin 10 mg/40 mg daily. All medication regimens were unchanged for at least 6 months. None of his medications was altered. The patient had been seen in the clinic 5 weeks prior to presentation. At that time, his INR was 2.0 and he received unspecified dose of INFLUENZA vaccine (unknown route, unknown injection site). Lot number was not available. 5 weeks after vaccination with INFLUENZA vaccine, the subject was hospitalized after becoming unresponsive at home. At the admission, the patient had been unresponsive for approximately 1 hour. The patient was experiencing rectal bleeding for the previous 2 days. The initial international normalized ratio (INR) was greater than 15; INR values over the previous 6 months were relatively stable. Relevant test were performed and showed the following results: Hemoglobin: 8.3 g/dL (normal range 14-18); Hematocrit: 24% (normal range 42-52); Platelet count: 412 x 10^3/uL (normal range 150-430); low serum albumin: 3.1 g/dL (normal range 3.5-5.0); total bilirubin: 0.8 mg/dL (normal range 0.2-1.0); aspartate aminotransferase: 16 IU/L (normal range 10-42); alanine aminotransferase: 12 IU/L (normal range 10-40); blood pressure: 166/60 mm Hg, heart rate: 62 beats/min; respiration rate: 16 breaths/min; temperature was not documented. A non-contrast computed tomography scan of the head revealed a large parenchymal hemorrhagic infarction involving the left temporal, parietal, and occipital lobes. The radiologist noted a significant mass effect including 12mm rightward midline shift and impending uncal herniation. The subject was treated in the emergency department with Nitroglycerin infusion to maintain systolic blood pressure in the range of 140-160 mm Hg as well as the infusion of 4 units of fresh frozen plasma and 10 mg of vitamin K. Following a neurosurgery evaluation, it was determined that nothing meaningful could be done to alter the patient's outcome positively. Comfort measures were implemented and the patient died approximately 17 hours after admission. The author considered the events were possibly related to the interaction between warfarin and vaccination with INFLUENZA vaccine.
Age: 64.0
Sex: M
Vaccine: FLUX
Symptoms: International normalised ratio increased, Platelet count increased, Rectal haemorrhage, Unresponsive to stimuli
Clinical narrative: This case was reported in a literature article and described the occurrence of hemorrhagic cerebral infarction in a 64-year-old male subject who was vaccinated with INFLUENZA virus vaccine (manufacturer unspecified). Concurrent medical conditions included atrial fibrillation, chronic obstructive pulmonary disease, depression, diabetes mellitus (type 2), gastroesophageal reflux, hypercholesterolemia and hypertension. Concurrent medications included warfarin 5 mg every other day alternating with 2.5 mg, celecoxib 200 mg as needed for pain, ipratropium/albuterol inhaler 2 puffs twice daily, diltiazem 120 mg twice daily, metformin 500 mg twice daily, hydrochlorothiazide/losartan 25 mg/100 mg daily, escitalopram 20 mg daily, lansoprazole 30 mg daily, propranolol 40 mg twice daily, and ezetimibe/simvastatin 10 mg/40 mg daily. All medication regimens were unchanged for at least 6 months. None of his medications was altered. The patient had been seen in the clinic 5 weeks prior to presentation. At that time, his INR was 2.0 and he received unspecified dose of INFLUENZA vaccine (unknown route, unknown injection site). Lot number was not available. 5 weeks after vaccination with INFLUENZA vaccine, the subject was hospitalized after becoming unresponsive at home. At the admission, the patient had been unresponsive for approximately 1 hour. The patient was experiencing rectal bleeding for the previous 2 days. The initial international normalized ratio (INR) was greater than 15; INR values over the previous 6 months were relatively stable. Relevant test were performed and showed the following results: Hemoglobin: 8.3 g/dL (normal range 14-18); Hematocrit: 24% (normal range 42-52); Platelet count: 412 x 10^3/uL (normal range 150-430); low serum albumin: 3.1 g/dL (normal range 3.5-5.0); total bilirubin: 0.8 mg/dL (normal range 0.2-1.0); aspartate aminotransferase: 16 IU/L (normal range 10-42); alanine aminotransferase: 12 IU/L (normal range 10-40); blood pressure: 166/60 mm Hg, heart rate: 62 beats/min; respiration rate: 16 breaths/min; temperature was not documented. A non-contrast computed tomography scan of the head revealed a large parenchymal hemorrhagic infarction involving the left temporal, parietal, and occipital lobes. The radiologist noted a significant mass effect including 12mm rightward midline shift and impending uncal herniation. The subject was treated in the emergency department with Nitroglycerin infusion to maintain systolic blood pressure in the range of 140-160 mm Hg as well as the infusion of 4 units of fresh frozen plasma and 10 mg of vitamin K. Following a neurosurgery evaluation, it was determined that nothing meaningful could be done to alter the patient's outcome positively. Comfort measures were implemented and the patient died approximately 17 hours after admission. The author considered the events were possibly related to the interaction between warfarin and vaccination with INFLUENZA vaccine.
Sex: M
Vaccine: FLUX
Symptoms: Abdominal pain, Arthralgia, Biopsy kidney abnormal, Cerebral haemorrhage, Condition aggravated
Clinical narrative: This case was reported in a literature article and described the occurrence of fatal exacerbation of glomerulonephritis in an adult male subject who was vaccinated with influenza virus vaccine (manufacturer unspecified). At the age of 12 years, the subject was diagnosed with PR3-ANCA-associated glomerulophritis due to Wegener's granulomatosis. He was treated with Cyclophosphamide, Meprednisone and Azathioprine. During the follow-up from 1999 to 2004, the subject suffered from several relapses that were treated with cyclophosphamide or methotrexate in combination with corticosteroids. In 2004, the subject developed a biopsy-proven renal relapse. Deoxyspergualin, an antiproliferative drug with effects on lymphocytes and macrophage function and neutrophil production, was started in combination with high doses of steroids. During the 1st three cycles, a partial remission was induced. Because hematuria and proteinuria persisted, the kidney was re-biopsied and showed persistently active glomerulonephritis with new necrotizing and crescentic lesions. The 4th and 5th cycles went uncomplicated. In the 6th cycle, the subject received unspecified dose of Influenza virus vaccine (unknown route and injection site), lot number not provided. Shortly after vaccination, a severe relapse occurred with purpura, arthralgias, new nodular lung lesions and active glomerulonephritis. Deoxyspergualin was stopped and mycophenolate mofetil in combination with high-dose corticosteroids and plasma exchange was given. Despite this therapy, the subject developed a severe ulceration of the legs, abdominal pain with bloody diarrhea and intercerebral haemorrhage due to cerebral vasculitis, resulting in death. The vaccination was done while the subject had an active glomerulonephritis suggesting that activation of the vasculitic process after influenza vaccination was cause by so-called bystander activation in which the vaccination resulted in activation of antigen presenting cells expressing the autoantigen proteinase 3. The author considered the events were possibly related to vaccination with Influenza virus vaccine. The subject died, cause of death is not specified. It was unknown whether an autopsy was performed.
Sex: M
Vaccine: FLUX
Symptoms: Death, Diarrhoea haemorrhagic, Glomerulonephritis, Haematuria, Immune system disorder
Clinical narrative: This case was reported in a literature article and described the occurrence of fatal exacerbation of glomerulonephritis in an adult male subject who was vaccinated with influenza virus vaccine (manufacturer unspecified). At the age of 12 years, the subject was diagnosed with PR3-ANCA-associated glomerulophritis due to Wegener's granulomatosis. He was treated with Cyclophosphamide, Meprednisone and Azathioprine. During the follow-up from 1999 to 2004, the subject suffered from several relapses that were treated with cyclophosphamide or methotrexate in combination with corticosteroids. In 2004, the subject developed a biopsy-proven renal relapse. Deoxyspergualin, an antiproliferative drug with effects on lymphocytes and macrophage function and neutrophil production, was started in combination with high doses of steroids. During the 1st three cycles, a partial remission was induced. Because hematuria and proteinuria persisted, the kidney was re-biopsied and showed persistently active glomerulonephritis with new necrotizing and crescentic lesions. The 4th and 5th cycles went uncomplicated. In the 6th cycle, the subject received unspecified dose of Influenza virus vaccine (unknown route and injection site), lot number not provided. Shortly after vaccination, a severe relapse occurred with purpura, arthralgias, new nodular lung lesions and active glomerulonephritis. Deoxyspergualin was stopped and mycophenolate mofetil in combination with high-dose corticosteroids and plasma exchange was given. Despite this therapy, the subject developed a severe ulceration of the legs, abdominal pain with bloody diarrhea and intercerebral haemorrhage due to cerebral vasculitis, resulting in death. The vaccination was done while the subject had an active glomerulonephritis suggesting that activation of the vasculitic process after influenza vaccination was cause by so-called bystander activation in which the vaccination resulted in activation of antigen presenting cells expressing the autoantigen proteinase 3. The author considered the events were possibly related to vaccination with Influenza virus vaccine. The subject died, cause of death is not specified. It was unknown whether an autopsy was performed.
Sex: M
Vaccine: FLUX
Symptoms: Lung neoplasm, Lymphocyte count abnormal, Plasmapheresis, Proteinuria, Purpura
Clinical narrative: This case was reported in a literature article and described the occurrence of fatal exacerbation of glomerulonephritis in an adult male subject who was vaccinated with influenza virus vaccine (manufacturer unspecified). At the age of 12 years, the subject was diagnosed with PR3-ANCA-associated glomerulophritis due to Wegener's granulomatosis. He was treated with Cyclophosphamide, Meprednisone and Azathioprine. During the follow-up from 1999 to 2004, the subject suffered from several relapses that were treated with cyclophosphamide or methotrexate in combination with corticosteroids. In 2004, the subject developed a biopsy-proven renal relapse. Deoxyspergualin, an antiproliferative drug with effects on lymphocytes and macrophage function and neutrophil production, was started in combination with high doses of steroids. During the 1st three cycles, a partial remission was induced. Because hematuria and proteinuria persisted, the kidney was re-biopsied and showed persistently active glomerulonephritis with new necrotizing and crescentic lesions. The 4th and 5th cycles went uncomplicated. In the 6th cycle, the subject received unspecified dose of Influenza virus vaccine (unknown route and injection site), lot number not provided. Shortly after vaccination, a severe relapse occurred with purpura, arthralgias, new nodular lung lesions and active glomerulonephritis. Deoxyspergualin was stopped and mycophenolate mofetil in combination with high-dose corticosteroids and plasma exchange was given. Despite this therapy, the subject developed a severe ulceration of the legs, abdominal pain with bloody diarrhea and intercerebral haemorrhage due to cerebral vasculitis, resulting in death. The vaccination was done while the subject had an active glomerulonephritis suggesting that activation of the vasculitic process after influenza vaccination was cause by so-called bystander activation in which the vaccination resulted in activation of antigen presenting cells expressing the autoantigen proteinase 3. The author considered the events were possibly related to vaccination with Influenza virus vaccine. The subject died, cause of death is not specified. It was unknown whether an autopsy was performed.
Sex: M
Vaccine: FLUX
Symptoms: Renal disorder, Renal necrosis, Skin ulcer, Vasculitis cerebral
Clinical narrative: This case was reported in a literature article and described the occurrence of fatal exacerbation of glomerulonephritis in an adult male subject who was vaccinated with influenza virus vaccine (manufacturer unspecified). At the age of 12 years, the subject was diagnosed with PR3-ANCA-associated glomerulophritis due to Wegener's granulomatosis. He was treated with Cyclophosphamide, Meprednisone and Azathioprine. During the follow-up from 1999 to 2004, the subject suffered from several relapses that were treated with cyclophosphamide or methotrexate in combination with corticosteroids. In 2004, the subject developed a biopsy-proven renal relapse. Deoxyspergualin, an antiproliferative drug with effects on lymphocytes and macrophage function and neutrophil production, was started in combination with high doses of steroids. During the 1st three cycles, a partial remission was induced. Because hematuria and proteinuria persisted, the kidney was re-biopsied and showed persistently active glomerulonephritis with new necrotizing and crescentic lesions. The 4th and 5th cycles went uncomplicated. In the 6th cycle, the subject received unspecified dose of Influenza virus vaccine (unknown route and injection site), lot number not provided. Shortly after vaccination, a severe relapse occurred with purpura, arthralgias, new nodular lung lesions and active glomerulonephritis. Deoxyspergualin was stopped and mycophenolate mofetil in combination with high-dose corticosteroids and plasma exchange was given. Despite this therapy, the subject developed a severe ulceration of the legs, abdominal pain with bloody diarrhea and intercerebral haemorrhage due to cerebral vasculitis, resulting in death. The vaccination was done while the subject had an active glomerulonephritis suggesting that activation of the vasculitic process after influenza vaccination was cause by so-called bystander activation in which the vaccination resulted in activation of antigen presenting cells expressing the autoantigen proteinase 3. The author considered the events were possibly related to vaccination with Influenza virus vaccine. The subject died, cause of death is not specified. It was unknown whether an autopsy was performed.
Age: 57.0
Sex: M
Vaccine: FLU(H1N1), FLU(H1N1), FLU(H1N1)
Symptoms: Abasia, CSF protein increased, CSF white blood cell count negative, Guillain-Barre syndrome, Muscular weakness
Clinical narrative: Weakness - difficulty walking and standing, stumbling, pains, spasms.
Age: 57.0
Sex: M
Vaccine: FLU(H1N1), FLU(H1N1), FLU(H1N1)
Symptoms: Asthenia, CSF protein increased, Guillain-Barre syndrome, Hyporeflexia, Lumbar puncture abnormal
Clinical narrative: Weakness - difficulty walking and standing, stumbling, pains, spasms.
Age: 57.0
Sex: M
Vaccine: FLU(H1N1), FLU(H1N1), FLU(H1N1)
Symptoms: Asthenia, Dysstasia, Gait disturbance, Laboratory test, Lumbar puncture
Clinical narrative: Weakness - difficulty walking and standing, stumbling, pains, spasms.
Age: 57.0
Sex: M
Vaccine: FLU(H1N1), FLU(H1N1), FLU(H1N1)
Symptoms: Muscle spasms, Nuclear magnetic resonance imaging, Pain
Clinical narrative: Weakness - difficulty walking and standing, stumbling, pains, spasms.
Age: 0.16
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC, RV5, DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Diarrhoea haemorrhagic, Food intolerance, Haematochezia
Clinical narrative: Baby developed diarrhea (12 stools a day, used to go every other day) started the day of vaccination. Was seen on 4-13-10 and had guaiac positive stool. Mom was put on dairy, soy, egg, wheat, fish/shell fish, nuts and citrus free diet and NUTRAMIGEN for supplement. Symptoms persisted. Saw GI and allergist. Suspected ROTATEQ triggered the colitis.
Age: 0.16
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC, RV5, DTAPIPVHIB, HEP, PNC, RV5
Symptoms: C-reactive protein normal, Colitis, Diarrhoea, Frequent bowel movements, Full blood count normal
Clinical narrative: Baby developed diarrhea (12 stools a day, used to go every other day) started the day of vaccination. Was seen on 4-13-10 and had guaiac positive stool. Mom was put on dairy, soy, egg, wheat, fish/shell fish, nuts and citrus free diet and NUTRAMIGEN for supplement. Symptoms persisted. Saw GI and allergist. Suspected ROTATEQ triggered the colitis.
Age: 0.16
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC, RV5, DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Occult blood positive, Radioallergosorbent test negative, Vaccination complication
Clinical narrative: Baby developed diarrhea (12 stools a day, used to go every other day) started the day of vaccination. Was seen on 4-13-10 and had guaiac positive stool. Mom was put on dairy, soy, egg, wheat, fish/shell fish, nuts and citrus free diet and NUTRAMIGEN for supplement. Symptoms persisted. Saw GI and allergist. Suspected ROTATEQ triggered the colitis.
Age: 36.0
Sex: F
Vaccine: JEV, PPV, TDAP
Symptoms: Asthenia, Chest discomfort, Chills, Injection site erythema, Injection site swelling
Clinical narrative: Fever, swelling 8 inches at (L) deltoid, red "patchy" areas at left arm. Nausea, chills, body achiness and weakness. Limited mobility of (L) arm. Slight chest tightness. Denies difficulty swallowing or breathing.
Age: 36.0
Sex: F
Vaccine: JEV, PPV, TDAP
Symptoms: Mobility decreased, Nausea, Pain, Pyrexia, Rash
Clinical narrative: Fever, swelling 8 inches at (L) deltoid, red "patchy" areas at left arm. Nausea, chills, body achiness and weakness. Limited mobility of (L) arm. Slight chest tightness. Denies difficulty swallowing or breathing.
Age: 1.0
Sex: M
Vaccine: PNC, VARCEL
Symptoms: Blister
Clinical narrative: Blisters on arms and legs.
Age: 1.04
Sex: M
Vaccine: MMR
Symptoms: Erythema, Pyrexia, Rash, Rash papular
Clinical narrative: 7/3 Fever of 102F 7/4 Fever, rash, and red bumps 7/5 Fever and rash (red bumps gone) 7/6 Rash only (fever gone) 7/7 Still has rash and seems to be spreading
Age: 35.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site mass, Injection site rash, Injection site swelling, Muscle spasms
Clinical narrative: Red bumps around injection site within one hour post injection.  Swelling, redness, quarter size lump over injection site, pain and muscle spasming x 22 days post injection.
Age: 35.0
Sex: F
Vaccine: FLU3
Symptoms: Pain
Clinical narrative: Red bumps around injection site within one hour post injection.  Swelling, redness, quarter size lump over injection site, pain and muscle spasming x 22 days post injection.
Age: 1.12
Sex: M
Vaccine: DTAP, HEPA, HIBV, MMR, PNC13, VARCEL
Symptoms: Blister, Varicella post vaccine
Clinical narrative: 07/07/2010 grandmother calls to report onset of "chickenpox" that started 07/03/2010 and client has vesicles on face, head, arms, legs.  Client had 1st varicella vaccine administered 06/18/2010.
Age: 11.0
Sex: M
Vaccine: HEPA, MNQ, TDAP
Symptoms: Convulsion
Clinical narrative: Pt had convulsion that last for approximately 30 seconds.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site warmth
Clinical narrative: Localized redness, itching, pain and warm to the touch at the injection site. Zostavax administered at 9:15 am. 9:20 am the patient was scratching at the site and it was red and painful. Ice pack applied and the patient was monitored for 30 minutes. No systemic reaction noted. Local reaction itching, pain, redness and warmth subsided.
Age: 0.51
Sex: F
Vaccine: DTAPIPV, HIBV, PNC, RV1
Symptoms: Expired drug administered
Clinical narrative: Pt was given an expired dose of ROTARIX. Vaccine expired 04/10. Dr. advised to redose patient with a non-expired dose of vaccine.
Age: 49.0
Sex: M
Vaccine: PPV
Symptoms: Acute respiratory distress syndrome, Chest X-ray abnormal, Chills, Continuous positive airway pressure, Cough
Clinical narrative: Within approx 24 hours of vaccine administration, the patient developed acute onset of SOB, and was seen in the ER. Found to have fever, chills, cough, bilateral infiltrates on CXR and suspected ARDs, admitted to ICU, hypotensive, ultimately intubated, required pressure, broad spect antibiotic but recovered, now well.
Age: 49.0
Sex: M
Vaccine: PPV
Symptoms: Dyspnoea, Endotracheal intubation, Hypotension, Intensive care, Lung infiltration
Clinical narrative: Within approx 24 hours of vaccine administration, the patient developed acute onset of SOB, and was seen in the ER. Found to have fever, chills, cough, bilateral infiltrates on CXR and suspected ARDs, admitted to ICU, hypotensive, ultimately intubated, required pressure, broad spect antibiotic but recovered, now well.
Age: 49.0
Sex: M
Vaccine: PPV
Symptoms: Pyrexia
Clinical narrative: Within approx 24 hours of vaccine administration, the patient developed acute onset of SOB, and was seen in the ER. Found to have fever, chills, cough, bilateral infiltrates on CXR and suspected ARDs, admitted to ICU, hypotensive, ultimately intubated, required pressure, broad spect antibiotic but recovered, now well.
Age: 4.0
Sex: M
Vaccine: FLU3
Symptoms: Dyspnoea, Swelling face, Wheezing
Clinical narrative: Combined initial and follow up report received from a healthcare professional on 29 Jun 2010 and on 30 Jun 2010, respectively: This patient was vaccinated with FLUVIRIN (batch number 960355P) 0.5ml dose, intramuscularly on 07 Oct 2009. 30 to 45 minutes after vaccination, the patient experienced wheezing, shortness of breath and swelling of face and was rushed to the emergency room. Final outcome of the events was not reported. The causality was reported as suspected.
Age: 55.0
Sex: F
Vaccine: HEP, MMR
Symptoms: Oedema peripheral, Rash erythematous, Rash pruritic
Clinical narrative: Happened on June 30, 2010, pre-employment process. On 6/30/10, received 2 vaccines (MMR and Hepatitis B). On 7/1 noted "red, itchy bumps" were forming on all extremities and swelling (L) arm. Saw doctor and received topical BENADRYL and PO Prednisone; bumps and swelling mostly resolved 7/7/10.
Age: 15.0
Sex: M
Vaccine: TDAP
Symptoms: Diarrhoea, Pyrexia, Vomiting
Clinical narrative: Vomited once on 7/6/10. Fever and diarrhea on 7/7/10.
Age: 1.25
Sex: F
Vaccine: HEPA, HIBV, PNC, TDAP
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 1.09
Sex: M
Vaccine: HEPA, MMR, PNC13, VARCEL
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: Right and left thighs turned red with "hive" like rash.  No wheeze.  BENADRYL & MILLIPRED given PO.
Age: 4.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Pt received DTaP to (R) deltoid on 6/29/10. Has a 7 x 11 cm duration erythema = red, warm and firm.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Lt. deltoid swoll. Red - hot.
Age: 63.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Injection site erythema, Injection site nodule, Injection site pain, Injection site warmth
Clinical narrative: Left upper arm developed a large nodule that was tender red and warm.
Age: 2.0
Sex: M
Vaccine: DTAP, HEPA, PNC13
Symptoms: Chest X-ray normal, Convulsion, Full blood count, Laboratory test normal, Unresponsive to stimuli
Clinical narrative: MOC called office at 3 PM.  Pt had a seizure and was unresponsive.  They were on there way to ER.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Chest X-ray, Haematology test, Pyrexia, Urine analysis
Clinical narrative: Fever 100 degrees F - 104 degrees.
Age: 47.0
Sex: F
Vaccine: HPV4
Symptoms: Discomfort, Hypoaesthesia, No reaction on previous exposure to drug, Pain in extremity, Paraesthesia
Clinical narrative: Information has been received from a physician concerning a 47 year old "transplant" female patient with allergy to gentamicin, alpha-1 anti-trypsin deficiency and a history of influenza vaccination in September 2009 who on 15-MAR-2010 was vaccinated IM with her first 0.5 ml dose of GARDASIL (lot #663559/1178Y), which was required in order to be put on the transplant list. Concomitant therapy included vitamin D (unspecified), PERCOCET, calcium (unspecified), multi vitamin, albuterol, SPIRIVA, "ALIST", tuberculin purified protein derivative (PPD) and ADVAIR. The patient did not have any problems after receiving the first dose of GARDASIL. On 08-JUN-2010, in the morning, the patient was vaccinated IM with her second 0.5 ml dose of GARDASIL (lot # 662765/0821Y) in her right arm. The patient had the impression that the nurse gave her the second dose of GARDASIL at a higher location than the location of the first dose. In the afternoon, the patient received PPD in her left forearm. On 08-JUN-2010 the patient experienced tingling and numbness of the entire right arm and pain on the entire right arm. It was pretty uncomfortable. The patient sought medical attention by an office visit and telephone calls. At the time of the report, the tingling and numbness persisted. No laboratory or diagnostic studies were performed. The reporting physician considered tingling, pain and numbness on the entire right arm to be disabling. Additional information has been requested.
Age: 26.0
Sex: F
Vaccine: HEPA, TYP, YF
Symptoms: Clonus, Dizziness, Feeling abnormal, Hyperhidrosis, Laboratory test normal
Clinical narrative: Seconds after vac pt c/o dizziness "feels funny" sweaty, felt faint (+) nausea - momentarily unresponsive verbally - clonic movement all kept drawing toward mid abdomen - No seizure activity, or incontinence - No tongue biting - 911 called.
Age: 26.0
Sex: F
Vaccine: HEPA, TYP, YF
Symptoms: Nausea, Unresponsive to stimuli
Clinical narrative: Seconds after vac pt c/o dizziness "feels funny" sweaty, felt faint (+) nausea - momentarily unresponsive verbally - clonic movement all kept drawing toward mid abdomen - No seizure activity, or incontinence - No tongue biting - 911 called.
Age: 0.18
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Screaming
Clinical narrative: Screaming spell - symptoms. Give patient TYLENOL every 4-6 hrs-prn-for pain.
Age: 3.0
Sex: M
Vaccine: PNC13
Symptoms: Rash papular
Clinical narrative: Rash small, red papules on buttock.
Age: 68.0
Sex: F
Vaccine: TD
Symptoms: Arthralgia, Cognitive disorder, Dizziness, Fatigue, Pyrexia
Clinical narrative: achiness in joints, fever, cognitive problems, dizziness and fatigue lasting 9 days
Age: 0.33
Sex: F
Vaccine: 6VAX-F
Symptoms: Injection site mass
Clinical narrative: DIME SIZE LUMP AT SITE OF INJECTION. REMAINS UNCHANGED, NON-TENDER TO TOUCH. NO SWELLINGS NOTED JUST THAT LUMP TO THE LEFT VASTUS LATERALIS
Age: 47.0
Sex: F
Vaccine: TDAP
Symptoms: Hypoaesthesia oral, Nausea
Clinical narrative: Started feeling queasy about an hour after vaccination. Then nauseated with circumoral numbness that is resolving 3 hrs later.
Age: 3.0
Sex: M
Vaccine: DTAPIPVHIB, HEP, HEPA, MMRV, PNC13
Symptoms: Hallucination, Pyrexia, Vomiting
Clinical narrative: Evening of 6-17-10 fever of 102.9 degrees F, vomiting, hallucinating (stated he was seeing spiders all over). Given ibuprofen but aunt/guardian stated it would not keep fever down for more than 2 hrs. Referred to family MD or pediatrician by Health Dept. On follow up call by Health Dept. guardian stated he was not seen by MD - fever gone after 3 days.
Age: 40.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Erythema, Lethargy, Localised oedema, Rash
Clinical narrative: Localized edema and erythema 5/26 rash onset approx. 6/15. Pt states around 13 vesicles all of which are dried at present. Denies any drainage at time of vesicles, positive lethargy during outbreak.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, HEPA, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Received kindergarten shots.  Left leg swollen, red/warm; started later in day after immunizations.  Using TYLENOL/MOTRIN and cool compresses.
Age: 32.0
Sex: M
Vaccine: TDAP
Symptoms: Body temperature increased, Chest X-ray normal, Chills, Full blood count normal, Hypoaesthesia
Clinical narrative: Severe chills, and fever of 102.7. Numbness and tingling of both upper extremities. Mottling of both upper extremities. Patient taken to ER at 10:48 AM. Upon admission, Temp 103.9, BP 153/77, HR 103. IV fluids and Ceftriaxam given. CXR performed and blood work done. All negative. After 2 hours, patient sent home. Fever down to 101. Chills and body aches continued throught the next 24 hours.
Age: 32.0
Sex: M
Vaccine: TDAP
Symptoms: Livedo reticularis, Pain, Paraesthesia, Pyrexia
Clinical narrative: Severe chills, and fever of 102.7. Numbness and tingling of both upper extremities. Mottling of both upper extremities. Patient taken to ER at 10:48 AM. Upon admission, Temp 103.9, BP 153/77, HR 103. IV fluids and Ceftriaxam given. CXR performed and blood work done. All negative. After 2 hours, patient sent home. Fever down to 101. Chills and body aches continued throught the next 24 hours.
Age: 1.3
Sex: F
Vaccine: DTAP, HIBV
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Noted an erythematous induration about 9.6 cm by 6.5 cm on the (R) thigh (anterior). Pt was not in pain, not bothered by it, kept walking across the room, opening doors, cabinets, very active and playful.
Age: 0.36
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Urticaria
Clinical narrative: Hives post vaccine administration (within 5 min).  No shortness of breath.  BENADRYL 12.5/5 1/2 tsp given -> hives resolved ( < 1 min).
Age: 2.0
Sex: M
Vaccine: HEPA, PNC13
Symptoms: Injection site swelling, Injection site warmth, Vaccination complication
Clinical narrative: Mom noticed left thigh was swollen, warm at site of immunization during his nap this afternoon 6/29/10; acting fine otherwise - walking well. No fever. Normal appetite. No acting fussy. Assessment: bacterial vaccination reaction; left ant thigh. Plan: cold compress, TYLENOL prn. Return to office if decrease in use left leg; development of fever and irritability.
Age: 11.0
Sex: F
Vaccine: HEPA, MNQ, TDAP
Symptoms: Syncope
Clinical narrative: Syncope.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMRV
Symptoms: Oropharyngeal pain, Rash papular, Streptococcus test positive
Clinical narrative: Developed papules on chest, neck and legs. Began 6/28/10. Also has sore throat. Positive strep test.
Age: 56.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Rash
Clinical narrative: Received TDAP/ADACEL injection 6-28-10 6:30 PM.  On 6-30-10 10AM arm sore, red, swollen at injection site size of 50 cent piece.  On 7-1-10 rash on top of left breast.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Blood glucose increased, Condition aggravated, Convulsion, Loss of consciousness, Postictal state
Clinical narrative: 5 min. after receiving vaccines patient syncopized and had loss of consciousness for about 5 s. Awoke briefly and then had 5-10s of seizure like activity. Patient was then post ictal and vomited x 1. Office called ambulance. Patient was reexamined and fingerstick done.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Syncope, Vomiting
Clinical narrative: 5 min. after receiving vaccines patient syncopized and had loss of consciousness for about 5 s. Awoke briefly and then had 5-10s of seizure like activity. Patient was then post ictal and vomited x 1. Office called ambulance. Patient was reexamined and fingerstick done.
Age: 45.0
Sex: F
Vaccine: FLU(H1N1), TDAP
Symptoms: CSF cell count normal, Electromyogram normal, Lumbar puncture normal, Muscle tightness, Muscular weakness
Clinical narrative: Approximately 18 hours after H1N1 vaccine, awoke with BLE weakness, aching pain, muscle tightness. No treatment. MS confirmed T7 myelopathy, neg. LP.
Age: 45.0
Sex: F
Vaccine: FLU(H1N1), TDAP
Symptoms: Myelopathy, Nuclear magnetic resonance imaging abnormal, Nuclear magnetic resonance imaging normal, Pain
Clinical narrative: Approximately 18 hours after H1N1 vaccine, awoke with BLE weakness, aching pain, muscle tightness. No treatment. MS confirmed T7 myelopathy, neg. LP.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Abasia, Fatigue, Hypersensitivity, Nodule on extremity, Oedema peripheral
Clinical narrative: Grandmother reports patient developed rash on Friday 5/21/10 that they thought was poison ivy and fever/fatigue by Sunday 5/23/10. Patients feet were swollen with "knots on soles feet; hands also swollen and patient could not walk. Went to ER; diagnosed with allergic reaction with prescription given.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Grandmother reports patient developed rash on Friday 5/21/10 that they thought was poison ivy and fever/fatigue by Sunday 5/23/10. Patients feet were swollen with "knots on soles feet; hands also swollen and patient could not walk. Went to ER; diagnosed with allergic reaction with prescription given.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Anaphylactic reaction, Blood glucose increased, Blood sodium normal, Respiratory distress
Clinical narrative: Anaphylaxis with respiratory distress about 10-15 minutes after vaccination with DTAP-IPV, MMR, VARIVAX. Required epinephrine, O2, albuterol, BENADRYL, SOLUMEDROL.
Age: 69.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Oedema peripheral, Skin induration, Skin warm
Clinical narrative: Arm became swollen and red. It was very hot and hard to touch.
Age: 1.5
Sex: F
Vaccine: PNC
Symptoms: Gait disturbance, Pain, Pyrexia, Wrong technique in drug usage process
Clinical narrative: Daughter refused to use leg in which vaccine was administered. She was acting paralyzed and in a lot of pain. She refused to walk all day. The following three days she was limping and walking much less than normal. Also had a fever for 3 days.
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Arthralgia, Headache, Injection site swelling, Lymph node pain, Lymphadenopathy
Clinical narrative: Headache, swelling at injection site, enlarged and painful axillary lymph nodes, myalgias and arthralgias, fever.
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Myalgia, Pyrexia
Clinical narrative: Headache, swelling at injection site, enlarged and painful axillary lymph nodes, myalgias and arthralgias, fever.
Age: 0.61
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Injection site urticaria
Clinical narrative: Mom, who is a pediatrician, notice hives on patient's legs the day after the vaccines were given. They appeared off and on over the next 4 days, mostly on her legs. No resp distress or facial swelling. Used Benadryl and she eventually did fine.
Age: 1.03
Sex: F
Vaccine: HEPA, HIBV, MMR, PNC13, VARCEL
Symptoms: Injection site induration, Injection site inflammation
Clinical narrative: 4/5 cm of inflammation at (L) thigh - 2/3 cm of induration not warm to touch.
Age: 58.0
Sex: M
Vaccine: MMR
Symptoms: Abasia, Arthralgia, Joint stiffness, Joint swelling
Clinical narrative: 58 y/o male seen 5/3/10 received polio and THYPHIM VI on 5/3/10 - (-) titer to MMR -> give MMR 5/18/10 - Approx 13 days after MMR both knees stiff, unable to walk, and swelling in joints worsened over week and include (R) wrist pain and stiffness. Required removal of synovial fluid on (L) knee for relief and steroid injection - Also had elbow pain and stiffness - Flex 30 degrees both knees severe pain - Symptoms resolved 6/6/10.
Age: 1.58
Sex: F
Vaccine: DTAP, HIBV, MMR
Symptoms: Gait disturbance, Oedema peripheral, Pain in extremity, Pyrexia
Clinical narrative: Day of vaccine began to have thigh swelling and pain, walking funny, and fever.
Age: 18.0
Sex: F
Vaccine: TDAP
Symptoms: Loss of consciousness
Clinical narrative: Patient passed out after injection for about 2 minutes gave pt ammonia inhalant, water, propped leg in chair, cold cloth to neck.
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Swelling, redness and arm hot to touch at injection site (GARDASIL) the evening of receiving the vaccine.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site cellulitis, Rash erythematous
Clinical narrative: On 7/2/10 seen for erythematous rash/cellulitis on Lft thigh treated with Cephalexin 200mg Q6hrx7days. On 7/7/10 nurse contacted area on Lft. thigh resolved. Pt. has been afebrile entire time.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash vesicular
Clinical narrative: Varicella like rash seen by doctor (Dermatology) for scraping/biopsy, rash on trunk and arms and face. Acyclovir admin.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMR
Symptoms: Injection site erythema, Injection site swelling, Skin warm
Clinical narrative: From top of shoulder down to elbow on arm, pt had redness, swelling, and warm skin, 2 days after shot.  Pt advised to take antihistamine per MD.  (on left arm where KINRIX imm. had been given).
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMRV
Symptoms: Injection site erythema, Injection site warmth, Pallor
Clinical narrative: 4.5 x 4.5 cm circular erythematous blanchable warm to touch lesion on (L) ant lateral thigh.
Age: 0.17
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Crying, Diet refusal, Irritability
Clinical narrative: 3 hrs after vaccine given-began crying. Mom says cry was unusual in that high pitched and cried hard for 1.5 hrs refused to nurse. Gave 1st dose of TYLENOL 1hr after started crying. Cried self to sleep, awoke fussy but improved. Later that evening feeding better and less fussy. No longer crying.
Age: 23.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Blood test, Cellulitis, Erythema, Induration, Oedema
Clinical narrative: Received PNEUMOVAX-noticed redness next day edema with redness increased to 5 inches induration acquired cellulitis.
Age: 5.0
Sex: F
Vaccine: DTAP, HEPA, IPV, MMR
Symptoms: Angioedema
Clinical narrative: 7cm x 7cm area of angioedema surrounding vaccine site on L thigh.
Age: 47.0
Sex: F
Vaccine: MMR
Symptoms: Influenza like illness, Pain, Rash, Rubella antibody negative
Clinical narrative: On 6/18/10 reported flu like symptoms, but no fever, "last week". On 6/17/10 after work noted rash on back, by the morning of 6/18 rash extended to trunk and face. MOTRIN 600mg po helped aches. He was taken off duty, he returned to work 6/28/10.
Age: 0.4
Sex: M
Vaccine: DTAPIPVHIB, PNC13
Symptoms: Body temperature increased, Crying
Clinical narrative: #2 imms due today - mother reported infant cried most of the day with #1 set - a slight elevation in temperature but not recorded. Resolved by night. #2 set given with plan to follow-up 6/22. TC 6/22 - mother reports infant cried for 4 hours and when he awoke next day cried most of morning. No other symptoms reported.
Age: 11.0
Sex: F
Vaccine: TDAP
Symptoms: Dizziness, Syncope
Clinical narrative: Was given immunization Tdap, pt became dizzy 5-6 min after vaccine, she was sitting down and fainted for a few seconds. She was taken to exam room to lay down x10 mins to recover, a cool damp towel was placed on forehead and behind the neck. She felt better and was released home.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Erythema, Feeling hot, Pain, Pruritus
Clinical narrative: Reaction started 7-4-10 redness, skin indurated, large blisters 10 x 7 area. Hot, itching, aching.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Skin induration
Clinical narrative: Reaction started 7-4-10 redness, skin indurated, large blisters 10 x 7 area. Hot, itching, aching.
Age: 12.0
Sex: F
Vaccine: TDAP, VARCEL
Symptoms: Malaise, Oxygen saturation normal, Unresponsive to stimuli
Clinical narrative: Ten minutes after receiving Imm pt. c/o not feeling good. Pt told to sit down, few seconds later pt. was unresponsive in chair lasting about a second responded to stimuli (shaking & calling name). Pt responded by asking what had happen. Left on own with parent 20 mins later.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Erythema, swelling and warm to touch to the right deltoid region.
Age: 0.19
Sex: F
Vaccine: DTAPIPVHIB, PNC, RV5
Symptoms: Diarrhoea
Clinical narrative: Diarrhea began the same day that she was administered ROTATEQ, PENTACEL and PREVNAR at 2 month well child exam.
Age: 2.0
Sex: M
Vaccine: PNC13
Symptoms: Urticaria
Clinical narrative: Mom called 6-28-10 child taken to ER due to hives no wheeze.  ER dx generalized hives tx orapred BENADRYL.  Child seen by Dr at health dept 6-29-10.  No wheeze, hives cheeks, thigh, upper arms, treatment BENADRYL.  Nurse called father 7-1-10 child better, hives resolving.